Hypermitotic meningiomas had the worst overall survival of all three groups and were distinguished by upregulation of FOXM1 expression, which was found to regulate DNA damage response, potentially increasing hypermitotic meningioma resistance to cytotoxic therapy (105). The gene discussed is FOXM1; the disease is meningioma.